Doxazosin 4 mg ER Tablets Manufacturer in India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Doxazosin 4 mg ER Tablets are extended-release alpha blocker medicines prescribed for hypertension management and benign prostatic hyperplasia associated with urinary flow difficulty and elevated vascular resistance.

The formulation contains Doxazosin in an extended-release dosage form that helps relax vascular smooth muscles and prostate tissues, supporting improved blood circulation and reduction of urinary obstruction symptoms in BPH patients.

Genliva Wellness LLP manufactures these formulations as a Doxazosin Extended Release Tablets Manufacturer in India, while also operating as a Benign Prostatic Hyperplasia Medicine Supplier and Alpha Blocker Tablets Exporter for cardiovascular and urology healthcare markets.

Doxazosin 4 mg ER Tablets are formulated for cardiovascular and prostate management therapy.

Extended-release alpha blocker formulation
Frequently utilized in BPH and hypertension management
Supports urinary flow improvement therapies
Helps reduce vascular smooth muscle resistance

This formulation is prescribed in cardiovascular and urology management therapies.

Treatment of hypertension conditions
Management of benign prostatic hyperplasia
Administered in urinary flow support therapies
Utilized in prostate enlargement management

Doxazosin 4 mg ER Tablets deliver extended-release alpha blocker support for cardiovascular and prostate care.

Valuable in BPH symptom management
Frequently preferred in urinary flow improvement care
Effective long-acting antihypertensive therapy support
Useful in prostate enlargement management

Doxazosin ER Tablet

Doxazosin ER Tablet